Literature DB >> 16936801

Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin.

Romy Fischer1, Hajer Debbabi, Michel Dubarry, Prosper Boyaka, Daniel Tomé.   

Abstract

In recent years, Lf has gained increasing interest as a result of its protective effects against a variety of diseases. While iron binding and interactions with mammalian receptors and microbial components are the best described mechanisms of action, recent studies have provided evidence that Lf properties may be related to immunoregulatory effects on Th1/Th2 cell activities. In vitro and in vivo experiments show that Lf is able to stimulate the differentiation of T cells from their immature precursors through the induction of the CD4 antigen. Studies performed under nonpathogenic conditions have shown distinct results with regard to the ability of Lf to support the proliferation and differentiation of Th cells into the Th1 or the Th2 phenotype. In addition, Lf plays different roles in diseases by affecting the Th1/Th2 cytokine balance in a manner dependent on the host's immune status. Thus, Lf could cause a Th1 polarization in diseases in which the ability to control infection or tumor relies on a strong Th1 response. Lf may also reduce the Th1 component to limit excessive inflammatory responses. Finally, Lf may provide protection against Th1- or Th2-induced diseases, such as autoimmune or allergic diseases, through correction of the Th1/Th2 imbalance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936801     DOI: 10.1139/o06-058

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  21 in total

Review 1.  The Iron age of host-microbe interactions.

Authors:  Miguel P Soares; Günter Weiss
Journal:  EMBO Rep       Date:  2015-10-16       Impact factor: 8.807

2.  Immunomodulatory effects of recombinant lactoferrin during MRSA infection.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Int Immunopharmacol       Date:  2014-03-06       Impact factor: 4.932

3.  Anti-neoplastic and immunomodulatory potency of co-treatment based on bovine lactoferrin and/or muramyl dipeptide in tumor-bearing mice.

Authors:  Hany M Ibrahim; Azza H Mohamed; Mohamed L Salem; Gamalat Y Osman; Dalia S Morsi
Journal:  Toxicol Res (Camb)       Date:  2020-04-24       Impact factor: 3.524

4.  Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes.

Authors:  Shen-An Hwang; Katarzyna M Wilk; Yogesh A Bangale; Marian L Kruzel; Jeffrey K Actor
Journal:  Med Microbiol Immunol       Date:  2007-03-22       Impact factor: 3.402

Review 5.  Lactoferrin and necrotizing enterocolitis.

Authors:  Michael P Sherman
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

6.  Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen.

Authors:  Shen-An Hwang; Kerry J Welsh; Sydney Boyd; Marian L Kruzel; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2011-11-15       Impact factor: 3.131

Review 7.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 8.  Iron overload and immunity.

Authors:  Graça Porto; Maria De Sousa
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

9.  Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Biochimie       Date:  2008-04-27       Impact factor: 4.079

10.  Significant transcriptome and cytokine changes in hepatitis B vaccine non-responders revealed by genome-wide comparative analysis.

Authors:  Shaohui Qiu; Peng He; Xin Fang; Haiqing Tong; Jingjing Lv; Jiaye Liu; Li Zhang; Xiangjun Zhai; Liying Wang; Zhongyu Hu; Yongli Yu
Journal:  Hum Vaccin Immunother       Date:  2018-05-14       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.